On the other hand, treatment with an EGFR (epidermal growth factor receptor) inhibitor also prevented the overgrowth caused by Nf2 deletion, suggesting that multiple pathways downstream of NF2 may be altered and contribute to HCC [100]. This evidence concerns the gene NF2 and hepatocellular carcinoma.